To present the most recent evidence on beta-lactam hypersensitivity reactions in children.
INTRODUCTION
Beta-lactam allergy is among the most common drug allergies in children [1 & ]. The self-reported prevalence of beta-lactam allergy in children varies from 1.7 to 5.2%, the most frequent beta-lactam being amoxicillin [2] . Reactions to beta-lactams are generally classified as immediate and nonimmediate reactions. This classification originates from Terrados et al. [3] and was later adopted by the latest International Consensus (ICON) on Drug Allergy [4] . Immediate reactions occur within the 1st hour of drug administration and typically involve urticaria and/or other symptoms of anaphylaxis; nonimmediate reactions occur more than 1 h after drug administration and symptoms can range from maculopapular cutaneous reactions or delayed urticaria to more severe systemic drug reactions such as Drug Reaction with Eosinophilia and Systemic Symptoms or Steven-Johnson Syndrome [2] . Most reactions in children are nonimmediate mild reactions, defined as uncomplicated exanthemas without danger signs ]. Beta-lactam allergy is clearly overdiagnosed in the paediatric population, as the vast majority of children developing an exanthema during a betalactam treatment are labelled as allergic without a confirmatory allergic workup. This is mainly due to lack of access to an allergy specialist or fear of a more severe allergic reaction upon re-exposure [5] . However, most skin exanthemas occurring during betalactam treatment are likely due to underlying viral infections, which may mimic an allergic reaction [5, 6] , and the majority of children do not react on subsequent exposure to the index drug [5] . Betalactam allergy diagnosis relies on a complete allergy workup [1 & ]. The optimal timing of the allergy workup is not well defined and remains controversial. According to international guidelines (ICON) [4] , the allergy workup should be performed ideally 4-6 weeks after the complete resolution of symptoms, but this delay can be adapted depending on the type and severity of the initial reaction. Traditionally, the evaluation of drug allergy in paediatric patients consists of a complete clinical history, and depending on the type of reaction, skin tests, laboratory tests ( 2] . However, at present, there is no standardized DPT protocol in children [7] . This review aims to present the most recent evidence on beta-lactam hypersensitivity in children.
EVIDENCE FOR DRUG PROVOCATION TEST WITHOUT SKIN TESTING IN NONIMMEDIATE MILD REACTIONS TO BETA-LACTAMS
Based on adult guidelines, the investigation of nonimmediate mild hypersensitivity drug reactions in children has traditionally involved delayed-reading intradermal tests (IDTs) and patch tests as a first step, followed by DPTs in cases when skin tests are negative. However, multiple studies have questioned the utility of IDTs in children, which have been shown to have a low sensitivity [5, [8] [9] [10] and a low positive predictive value (PPV) [5,11 & ] in nonimmediate mild reactions. Caubet et al. [5, 12] performed IDTs and DPTs in 96 children with a history of mild nonimmediate reactions to beta-lactams, of which 14 were confirmed allergic. Seven had positive immediate reading-IDTs, and seven had positive DPTs with negative IDTs, giving a sensitivity of 50% [12] . Of note, none of the patients had positive delayed-reading IDTs or positive patch tests. Zambonino et al. [8] evaluated 783 children with a history of hypersensitivity reactions to beta-lactams, and 62 (7.92%) were confirmed allergic. In the 53 patients with nonimmediate reactions, two children had positive IDTs, whereas 51 were diagnosed by DPT with previously negative IDTs. Ponvert et al. [10] evaluated 1431 children and diagnosed nonimmediate beta-lactam allergy in 177 (12.4%). Nonimmediate beta-lactam allergy was confirmed by IDTs in 60 patients, whereas 104 children had positive DPTs with negative IDTs. Atanaskovic-Markovic et al. [9] evaluated 1026 children with a history of nonimmediate mild beta-lactam reactions. Seventy-six (7.4%) had confirmed nonimmediate reactions defined as positive skin tests or DPTs. Fifty-seven were confirmed by positive IDTs, whereas 19 had positive DPTs with previously negative IDTs [9] . The few studies that have examined the PPV of skin testing in mild nonimmediate drug reactions in children have shown that it is equally poor. In Caubet et al.'s [5] study, 11/88 children had a positive immediate-reading IDT, but only four of them had a mild exanthema when challenged, giving a PPV of 36% in that population. Vyles et al. [13] found that 3/100 children with a suspected betalactam allergy with positive skin tests had negative DPTs. More recently, Confino-Cohen et al. [14] performed IDTs followed by DPTs regardless of skin test results in 617 patients (of whom 66.6% were children) with nonimmediate reactions to beta-lactam. Again, there was no relationship between positive skin tests and DPT results, with 28 patients with positive IDTs having negative home DPTs. Hence, multiple studies have confirmed the poor diagnostic value of skin tests in children with nonimmediate mild reactions to beta-lactams and questioned their utility considering that they are painful and difficult to perform in children. The low diagnostic performance of skin tests in children might be explained by differences in interpretation of positive IDTs [15] and lack of standardization of those tests in the paediatric population. Skin thickness variability with age [16] may further complicate interpretation of tests.
Before proceeding to DPTs without skin test, one important question that needs to be considered is the safety of such an approach. Mill et al. [17 && ] performed direct graded DPTs without skin testing in children with a history of beta-lactam hypersensitivity. The majority of the 818 patients children evaluated in the study had nonimmediate benign
KEY POINTS
Most skin eruptions during beta-lactam treatment in children are likely due to viral infections, which can mimic an allergic reaction.
DPTs without skin testing can be considered in children with mild nonimmediate beta-lactam hypersensitivity reactions.
Some authors propose DPTs without skin testing in mild immediate reactions, although this approach is controversial and requires further multicentric studies.
The optimal length of DPTs for nonimmediate reactions to beta-lactams still needs to be defined. [24] [25] [26] . Furthermore, the current classification of beta-lactam hypersensitivity reactions in immediate or nonimmediate reactions is difficult to apply in clinical practice [27] . Parents often cannot provide a precise description of the time interval between the last culprit drug administration and the beginning of the hypersensitivity reaction. Moreover, it is not known if a child whose rash appears after a few days of antibiotics is due to the last given dose or previous dose.
In this context, Mill et al. [17 && ] performed graded DPTs to amoxicillin without skin tests in 818 children with a suspected amoxicillin allergy, irrespective of the delay from the last dose received. Close to 100 of those patients had a history of mild immediate reactions occurring within 1 h of drug administration. Although patients with anaphylaxis were not excluded, none were present in the cohort. Out of the 17 immediate reactions on DPT (around one-fifth had a history of immediate reactions), all were mild and consisted of hives. These patients were later skin-tested with benzylpenicillin and benzylpenicilloyl polylysine, and only one was positive, giving a poor sensitivity for these tests. Unfortunately, amoxicillin IDTs were not performed as amoxicillin is not available in an injectable form in Canada. Thus, the diagnostic value of skin testing is difficult to evaluate in this study as one of the major components of skin tests is missing. Of note, this study mainly included children less than 10 years of age (median of 1.7 years). Recently, Vyles et al. [11 & ] evaluated 302 children presenting to the paediatric emergency department with low-risk symptoms of penicillin allergy, as reported by parents or guardians, including immediate reactions (precise number not specified). The authors characterized as 'low-risk' the reactions that were not likely to represent a severe IgE-mediated or T-cell-driven process. A total of 100 children underwent penicillin allergy testing. An oral DPT was safely completed in every patient regardless of skin test findings, and all were negative. These previous studies go in line with a systematic review by Marrs et al. [25] concluding that nonserious beta-lactam allergies should be evaluated primarily with DPTbased clinical protocols. However, the evidence to support DPT without skin testing in benign immediate reactions remains limited and larger studies are still needed to confirm the safety of this approach. Indeed, considering that anaphylaxis is a very rare event in this population, multicentric studies will be needed to provide additional safety data pertaining to this approach.
STANDARDIZATION OF DRUG PROVOCATION TESTS
As previously discussed, DPTs are the gold standard when investigating hypersensitivity reactions to beta-lactams in children. However, there is no consensus on the optimal DPT protocol for investigating nonimmediate reactions, particularly regarding the length which ranges from 1 to 10 days On one hand, shorter protocols are more convenient and have fewer side effects, whereas longer protocols may increase the sensitivity of the DPT. Analysis of different protocols is complicated by methodological differences in studies.
Data from studies with extended beta-lactam DPT protocols in children have shown that late reactions during home DPT after a negative 1st day DPT occur in between 0 and 6.2% of patients [5,8- (Table 1) . Of note, reactions occurring on prolonged DPTs after the 1st day can still be linked to the first dose, which may result in an overestimation of delayed reactions with prolonged protocols. This concept was highlighted in a study by Chiriac et al. [32] , in which a significant proportion of positive DPTs occurred 24 h after a single-day DPT. The same group and others [31] [32] [33] provide evidence that upon re-exposure, most patients react earlier or in a similar amount of time than the initial reaction; in addition, they argue that adequate cumulative dose is more important than reproducing the timing of exposure, and that the time required to eliminate the antibiotic (seven halflives) is enough to activate an immune response by memory and effector T and B cells.
A few studies have evaluated the negative predictive value (NPV) of beta-lactam DPT protocols after re-exposure to the index drug 1 [ && ] study with a NPV of 96.7% for the 3-day DPT better reflects a 1-day DPT, because all patients reacted within 24 h. Other data from adult centres have shown a NPV of 94.1 [35] and 96% [32] for the 1-day DPT. Ultimately, the NPVs after a 1 day and an extended DPT seem comparable.
Furthermore, the percentage of patients that react on retreatment with culprit antibiotic after prolonged DPTs is generally not much greater than the incidence of skin rashes after a treatment with antibiotics in the paediatric population, which is estimated around 1-5% per prescription [36] . An interesting concept is the number needed to harm (NNH) when performing prolonged DPTs [32] . When looking at the percentage of patients who react on prolonged challenges, if we estimate that around 5% of patients react on extended DPTs, one can consider that around 95 healthy children are exposed to a prolonged course of antibiotics to screen only five patients with mild delayed reactions. Taking into account the previous statements and the fact that 1-day and extended DPTs have similar NPVs, a single-day DPT seems sufficient for the diagnosis of beta-lactam allergy in children and can help minimize the length of antibiotic exposure.
FUTURE COMPLIANCE AFTER DRUG PROVOCATION TEST
Some studies with extended antibiotic DPTs suggest that these may increase future compliance in patients and healthcare professionals. Ratzon et al.
[37] compared 26 children who underwent 7-day DPTs to 23 children who underwent a conventional 1-day DPT. They found that patients with longer DPT were more likely to use the antibiotic in the future when compared with the shorter DPT (78 vs. 61%, respectively). Another recent study by Labrosse et al. [18 & ] compared a 5-day amoxicillin DPT cohort of 114 children, to a previous similar cohort of 170 children published by the same authors who had undergone a single dose DPT. Twenty-five percentage of parents or physicians refused to give the antibiotic by fear of reaction after a single-day graded DPT compared with 1.3% after a 5-day DPT. 
RISKS OF PROLONGED DRUG PROVOCATION TESTS AND LONG-TERM EFFECTS
Use of antibiotics in children comes with side effects including disturbances of the intestinal microbiota, risk of microbial resistance [38] and obesity [39] . A 7-day treatment with amoxicillin was shown to significantly alter the gut microbiota in children (30% reduction of total faecal bacteria), which may favour the growth of pathogenic organisms and cause changes in the colonic microenvironment [40] . No studies have studied the effect of 1-day DPTs compared with prolonged protocols on the gut microbiota, although longer DPTs may presumably have a higher impact on gut flora and increase gastrointestinal side effects. In addition, there may be a risk of developing new beta-lactam sensitizations with extended DPTs.
IN-VITRO DIAGNOSTIC TESTS
Although not fully validated in the paediatric population, specific IgE are generally recommended during the workup of children with a suspicion of immediate reactions (Fig. 1) [42] recently evaluated 18 children with a clinical suspicion of immediate reactions to amoxicillin or amoxicillin-clavulanate. Reaction severity on DPT and skin tests did not correlate with BAT results in these children, although studies in adult populations seem promising for high-risk patients [43] . Altogether, data do not yet support the use of BAT during workup of penicillin allergic children.
Lymphocyte activation tests have shown promising results in adults with severe nonimmediate hypersensitivity reactions to beta-lactams [6] . However, they were shown to have a poor diagnostic value for mild nonimmediate reactions in children [12] , and further studies are required to determine their validity in this population.
NATURAL HISTORY OF BETA LACTAM ALLERGY
There are few prospective studies on the natural history of beta-lactam allergy in children. Blanca et al. [44] performed a prospective study in adults and found that a majority of patients with immediate reactions to penicillins and positive skin tests will lose their beta-lactam sensitivity to amoxicillin or benzyl penicillin determinants over a 5-year period. However, this does not necessarily imply tolerance acquisition as DPT was not performed. Tonson La Tour et al. [34 && ] recently performed a follow-up DPT after 3 years in children with a positive DPT to beta-lactams. In the study, 5/18 had immediate reactions, and 12/18 had nonimmediate reactions. Sixteen out of 18 (89%) had a negative DPT, and among these patients, 11 tolerated a subsequent treatment with the incriminated beta-lactam. These data support the fact that the majority of children with confirmed beta-lactam allergy (with both immediate and nonimmediate reactions) become tolerant after 3 years, although this is one study based on a limited number of patients. Further studies are still required to confirm these findings and to assess whether tolerance acquisition happens earlier.
CONCLUSION
A change in paradigm has recently occurred with recent studies supporting DPTs without skin testing for mild nonimmediate reactions to beta-lactams in children [24] . However, data are limited in the adolescent population, and this attitude may not apply to this age group. In addition, this approach cannot be recommended in mild immediate reactions due to limited data and the rarity of severe anaphylactic reactions. The optimal duration of DPT is still unknown, with extended protocols providing slightly more sensitivity and possible higher longterm compliance, at the expense of potential side effects linked with alteration of the gut microbiota and a high NNH. On the other hand, one dose will identify the vast majority of patients (NPV of 89.1-96.7%), and the rest will only develop a mild rash during a subsequent full treatment. Head-to-head studies are still needed to determine the optimal length taking into account the risk-benefit balance. Finally, additional prospective studies on the natural history of beta-lactam allergy in children are required.
